JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic InfectionFabien Zoulim, Jeysen Yogaratnam, Willem Talloen et al.|Gastroenterology|2020Cited by 116
HDV RNA assays: Performance characteristics, clinical utility, and challengesHeiner Wedemeyer, Pietro Lampertico, Mitchell Leus et al.|Hepatology|2023Cited by 48